Difference between revisions of "Mesna (Mesnex)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "manufacturer. Instead" to "manufacturer. Instead")
Line 15: Line 15:
  
 
==Also known as==
 
==Also known as==
Precise Name: Mesna (RXCUI 44)
+
*'''Brand names:''' Anti Uron, Mesa, Mesnex, Mesnil, Mestian, Mistabron, Mistabronco, Mitexan, Mucolene, Neper, Novacarel, Siruta, Uromes, Uromitexan, Uroprot, Varimesna
 
 
{| border="1" style="text-align:center;"
 
!colspan="8" align="center" style="background-color:#0066FF"| '''Synonyms'''
 
|-
 
|Anti Uron
 
|MEI AN
 
|Mesa
 
|Mesna-Cell
 
|Mesna Delta Farma
 
|Mesna Filaxis
 
|Mesna GI Kendrick
 
|Mesna Microsules
 
|-
 
|Mesnex
 
|Mesnil
 
|Mestian
 
|Mistabron
 
|Mistabronco
 
|Mitexan
 
|Mucolene
 
|Neper
 
|-
 
|Novacarel
 
|Siruta
 
|Uromes
 
|Uromitexan
 
|Uroprot
 
|Varimesna
 
|}
 
  
 
==References==
 
==References==

Revision as of 20:24, 4 February 2018

General information

Class/mechanism: Detoxifying agent to reduce the risk of hemorrhagic cystitis with agents such as Ifosfamide (Ifex). Mesna is rapidly metabolized to mesna disulfide (dimesna), which remains intravascular and is rapidly processed by the kidneys, where it is converted back into mesna. Mesna binds to the urotoxic metabolites of ifosfamide, acrolein and 4-hydroxy-ifosfamide, limiting the risk of hemorrhagic cystitis. It has not been shown to interfere with antitumor efficacy.[1][2]
Route: IV, PO
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

History of changes in FDA indication

  • 12/30/1988: Initial FDA approval

Also known as

  • Brand names: Anti Uron, Mesa, Mesnex, Mesnil, Mestian, Mistabron, Mistabronco, Mitexan, Mucolene, Neper, Novacarel, Siruta, Uromes, Uromitexan, Uroprot, Varimesna

References